drugset / Trial / NCT02382419

Carrageenan-Containing Gel in Reducing the Rate of HPV Infection in Healthy Participants

NCT02382419 ↗

RandomizedParallel-groupDouble-blindPrevention

Summary

This randomized phase II trial studies how well carrageenan-containing gel (vaginal gel) works in reducing the rate of human papilloma virus (HPV) infection in healthy participants. Carrageenans, which are naturally derived from seaweed, are enhancements to natural lubrication and may be effective in blocking HPV infection.

Timeline

Start
2016-02-24
Primary completion
2019-02-13
Completion
2019-02-13

Outcome

Outcome not reported

Stopped (Enrollment): “Principal Investigator Decided to stop recruitment in the trial.”

Drugs

EvaluationDrugModalityDoseRoute
Subject carrageenan-containing gel Unknown — Other